Skip to main content
Signal8

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

$IMNMPress releaseMay 5, 2026, 4:00 PM ETRead the release

Immunome granted inducement awards consisting of non-statutory stock options to purchase an aggregate of 450,000 shares to 19 new employees under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $22.73 per share, equal to the closing price on the grant date, and vest over four years.

Key figures

Exercise price
22.73
Shares granted
450000

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.